Ubicom Holdings, Inc. (3937) Stock Price

Ubicom Holdings operates two main business segments: Medical and Technology Consulting. In the Medical segment, the company develops and sells medical information system software for healthcare institutions, provides custom development services, and offers medical data analysis and consulting. Its flagship product is the receipt audit software series "MightyChecker®."

The Technology Consulting segment provides IT solutions across healthcare, finance, public sector, automotive, mobile, and real estate industries, primarily in Japan and the Philippines. By leveraging its Philippine subsidiary, the company delivers cost-effective, high-quality system development while maintaining global competitiveness.

Ubicom Holdings views societal changes and technological innovation as business opportunities and is deploying next-generation solutions for strategic markets including healthcare and finance. The company is advancing its "3A" strategy, which leverages AI and big data analytics, to drive medical data analysis and fintech-related system development.

In the Medical segment, subsidiary AI-S Corporation serves as the core operation, contributing to healthcare institutions' management challenges and digital transformation initiatives. Products such as the AI-powered next-generation receipt audit system "MightyChecker® EX" and "Mighty QUBE® Hybrid" are in high demand.

The Technology Consulting segment combines offshore development through its Philippine subsidiary with onshore development to provide optimal solutions tailored to customer needs. The company also strategically develops IT talent using Philippine personnel to address Japan's IT skills shortage.

Ubicom Holdings pursues a distinctive growth strategy aimed at solving social challenges through IT solutions. Under the philosophy of "Unique beyond comparison," the company pursues one-of-a-kind business innovation. The company also advances global expansion under the banner "Go Global," focusing on the United States and Asia.

The company's business development strategy centers on market creation and establishing the No. 1 position in niche markets. Leveraging the characteristics of each group company, it develops new markets and pursues growth. In particular, it deploys global business schemes centered on Asia to strengthen its revenue base.

In the Medical business, the company promotes new platform business leveraging medical data, centered on the "MightyChecker®" series. It strengthens data analytics platforms for life insurance companies and health insurance associations, advancing digital transformation in healthcare. Through this, it aims to create new subscription-based revenue streams.

In the Technology Consulting business, the company deploys next-generation solutions utilizing AI and big data for strategic domains such as healthcare and finance. Leveraging its offshore base in the Philippines, it develops talented IT personnel and aims to acquire high-margin projects.

As a company-wide initiative, Ubicom Holdings promotes the cultivation of new businesses and a Win-Win investment model with partner companies. It strengthens human capital investment and aims to establish new revenue pillars. In conjunction with its transition to the Prime Market, it is advancing improvements to its management structure.

In partnerships and strategic alliances, the company promotes M&A strategies domestically and internationally, advancing partnerships based on relationships with nationwide sales agents, particularly in the Medical business. Through these efforts, it aims to continuously enhance corporate value and realize its growth strategy.